BIRSA-101, recently in the news, is related to which of the following? |ForumIAS

Updates

Prelims Sprint 2026 (PRRC), Batch-1 Starts on 1st December 2025 available in Online and Offline Mode | PTS 2026 Batch-19 available in English & Hindi Medium, Starts on 19th November 2025 | CSAT Classes for 2026 Prelims, Batch-2 starts 4th November 2025 | Inviting Applications for SFG Residential ( FRC – 8/9 ), Program starts 10th December 2025

Q. BIRSA-101, recently in the news, is related to which of the following?

[A] A gene-editing technology for improving crop varieties

[B] A biotechnology scheme for tribal livelihood improvement

[C] A genome sequencing programme for rare diseases

[D] A CRISPR-based gene therapy for Sickle Cell Disease

Answer: D

Notes:

Explanation: BIRSA-101 is India’s first indigenous CRISPR-based gene therapy specifically developed to treat Sickle Cell Disease (SCD). It is named after tribal leader Birsa Munda, as SCD is highly prevalent among tribal populations. The therapy has been developed by the CSIR-Institute of Genomics and Integrative Biology (IGIB).

Source- PIB

Q. BIRSA-101, recently in the news, is related to which of the following?

Post-Mains Strategy Session by Mr. Ayush Sinha | ForumIAS